Argenx
ARGX
#476
Rank
NZ$86.33 B
Marketcap
NZ$1,386
Share price
-3.33%
Change (1 day)
19.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company